← Back to articles

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confidence neutral tone

Coverage (16767 articles)

News-Medical · Jul 01, 2026

Monoclonal antibody ALT-100 shows promise in early ARDS trial

A proof-of-concept study demonstrates that monoclonal antibody ALT-100, targeting inflammation regulator NAMPT, significantly improves outcomes in acute respiratory distress syndrome patients with 21 ventilator-free days versus 14 in placebo group.

← Previous Page 253 of 699 Next →
Contact Us FAQ